Disentangling concepts of inappropriate polypharmacy in old age: a scoping review

Abstract

Introduction Polypharmacy is a common concern, especially in the older population. In some countries more that 50% of all individuals over 60 receive five or more drugs, most often due to multimorbidity and increased longevity. However, polypharmacy is associated with multiple adverse events, and more medication may not always be the answer. The terms “appropriate” and “inappropriate” are often used to distinguish between “much” and “too much” medications in relation to polypharmacy in research and practice, but no explicit definition exists to describe what these terms encompass. The aim of this review is to unfold the different understandings of and perspectives on (in)appropriate polypharmacy and suggest a framework for further research and practice. Method A scoping review was conducted using the framework of Arksey and O’Malley and Levac et al. Pubmed, Embase, PsycINFO, CINAHL, Cochrane database, Scopus and Web of Science were searched for references in English, Danish, Norwegian and Swedish using the search string “Polypharmacy” AND “Appropriate” OR “Inappropriate”. Data was extracted on author information, aims and objectives, methodology, study population and setting, country of origin, main findings and implications, and all text including the words “appropriate,” “inappropriate,” and “polypharmacy.” Qualitative meaning condensation analysis was used and data charted using descriptive and thematic analysis. Results Of 3982 references, a total of 92 references were included in the review. Most references were from 2016-2021, from fields related to medicine or pharmacy, and occurred within primary and secondary healthcare settings. Based on the qualitative analysis, a framework were assembled consisting of Context, three domains (Standardization, Practices and Values & Concerns) and Patient Perspective. Conclusion Inappropriate polypharmacy is a concept loaded by its heterogeneity and the usefulness of a single definition is doubtful. Instead, the framework suggested in this article representing different dimensions of inappropriate polypharmacy may serve as an initial strategy for focusing research and practice on polypharmacy in old age.

Medicines use and polypharmacy in retirement village residents in Aotearoa New Zealand: a point prevalence observational study

“…11 Polypharmacy may, however, be appropriate to treat multiple long-term conditions and hence there is ever increasing attention paid to the concept of 'inappropriate' polypharmacy, whereby medicines are prescribed in excess of therapeutic need, or in ways that are harmful. 14 There are a number of medicine classes that are known to increase the risk of adverse drug events in older people, including hypnotics, antipsychotics, hypoglycaemics and anticoagulants, 15 which all featured in our current study. Hypnotics are associated with increased risk of confusion, muscle weakness, and falls, which impact older people to a greater extent than younger people, and in our study, these were prescribed at similar rates as those seen in the general 75+ years population in NZ.…”

The core symptom in multiple myeloma patients undergoing chemotherapy: a network analysis

“…The analgesic ladder, vertebroplasty, and complementary and alternative medicine were also effective in controlling pain [ 35 ]. However, the study showed that the polypharmacy increased mortality, falls, adverse drug reaction, and hospitalization and readmissions [ 38 ]. Decreasing the drug use of the patients are not necessary.…”

Exploring Polypharmacy and Drug Interactions in Geriatric Patients: A Cross-Sectional Study from India

“…Inappropriate polypharmacy and its associated adverse outcomes have prompted researchers to explore factors contributing to this phenomenon (Lau et al, 2023). Studies have identi ed several determinants of polypharmacy, including the presence of multiple chronic conditions, depressive symptoms, and prescribing practices (Chuang et al, 2023).…”